Trademark: DANYELZA NAXITAMAB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
DANYELZA NAXITAMAB
Click here to search for trademarks similar to DANYELZA NAXITAMAB
Proof of use for DANYELZA NAXITAMAB
We do not have any records of a proof of use for DANYELZA NAXITAMAB at this moment.
Possible trademark infringements of DANYELZA NAXITAMAB
Basic Information about DANYELZA NAXITAMAB
- Serial Number
- 88749157
- Filing Date
- 07 Jan 2020
- Registration Number
- 6214682
- Registration Date
- 08 Dec 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of DANYELZA NAXITAMAB on the blockchain with WikiTrademarks.io.
- First use of DANYELZA NAXITAMAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of DANYELZA NAXITAMAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns DANYELZA NAXITAMAB?
1. Y-mAbs Therapeutics, Inc New York NY
2. Y-mAbs Therapeutics, Inc New York NY
3. Y-mAbs Therapeutics, Inc New York NY
Correspondent
- Andrew N. Spivak
- MOSAIC LEGAL GROUP, PLLC
- 5185 MACARTHUR BOULEVARD, NW, SUITE 350
- WASHINGTON DC 20016-3341
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io